What Happened?
Vancouver, BC-based Zucara-Therapeutics Appointed Michael Midmer as Chief Executive Officer
About the Company
Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes.
About the Person
Michael Midmer is Chief Executive Officer at Zucara Therapeutics. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile